Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms

International Immunopharmacology

Volumn 30, Issue , 2016, Pages 179-187

  Liu, Jiaming ^a   Wang, Fangyan ^a   Luo, Haihua ^b   Liu, Aihua ^b   Li, Kangxin ^b   Li, Cui ^b   Jiang, Yong ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Butyrate; Cytokine; Gastric ulcer; Inflammation; Stress

Indexed keywords

BUTYRIC ACID; CARBONYL PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; OMEPRAZOLE; PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALCOHOL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; BUTYRIC ACID DERIVATIVE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIULCER ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGESTIVE TRACT PARAMETERS; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ETHANOL-INDUCED GASTRIC ULCER; GASTRIC MUCOSA; GASTRIC WALL MUCUS; HOST RESISTANCE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; STOMACH; STOMACH INJURY; STOMACH PROTECTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; HUMAN; METABOLISM; MUCOSAL IMMUNITY; STOMACH ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BUTYRATES; CYTOKINES; ETHANOL; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION MEDIATORS; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STOMACH ULCER;

EID: 84951567232     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.11.018     Document Type: Article

References (57)

1. R.B. Canani, M.D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano Potential beneficial effects of butyrate in intestinal and extraintestinal diseases World J. Gastroenterol. 17 12 2011 1519 1528
2. D. Scholz The role of nutrition in the etiology of inflammatory bowel disease Curr. Probl. Pediatr. Adolesc. Health Care 41 9 2011 248 253
3. P. Vernia, P.L. Fracasso, V. Casale, G. Villotti, A. Marcheggiano, V. Stigliano, and et al. Topical butyrate for acute radiation proctitis: randomised, crossover trial Lancet 356 9237 2000 1232 1235
4. E.L. Vieira, A.J. Leonel, A.P. Sad, N.R. Beltrao, T.F. Costa, T.M. Ferreira, and et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis J. Nutr. Biochem. 23 5 2012 430 436
5. W. Scheppach, H. Sommer, T. Kirchner, G.M. Paganelli, P. Bartram, S. Christl, and et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis Gastroenterology 103 1 1992 51 56
6. S.A. Di, R. Morera, R. Ciccocioppo, P. Cazzola, S. Gotti, F.P. Tinozzi, and et al. Oral butyrate for mildly to moderately active Crohn's disease Aliment. Pharmacol. Ther. 22 9 2005 789 794
7. W. Scheppach, and F. Weiler The butyrate story: old wine in new bottles Curr. Opin. Clin. Nutr. Metab. Care 7 5 2004 563 567
8. K.Y. Fung, L. Cosgrove, T. Lockett, R. Head, and D.L. Topping A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate Br. J. Nutr. 108 5 2012 820 831
9. K. Cooper, H. Squires, C. Carroll, D. Papaioannou, A. Booth, R.F. Logan, and et al. Chemoprevention of colorectal cancer: systematic review and economic evaluation Health Technol. Assess. (Winchester, England) 14 32 2010 1 206
10. K. Meijer, P. de Vos, and M.G. Priebe Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health Curr. Opin. Clin. Nutr. Metab. Care 13 6 2010 715 721
11. Z. Gao, J. Yin, J. Zhang, R.E. Ward, R.J. Martin, M. Lefevre, and et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice Diabetes 58 7 2009 1509 1517
12. S.P. Perrine, G.D. Ginder, D.V. Faller, G.H. Dover, T. Ikuta, H.E. Witkowska, and et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders N. Engl. J. Med. 328 2 1993 81 86
13. S.P. Perrine, S.A. Castaneda, D.H. Chui, D.V. Faller, R.J. Berenson, N. Siritanaratku, and et al. Fetal globin gene inducers: novel agents and new potential Ann. N. Y. Acad. Sci. 1202 2010 158 164
14. S.P. Perrine, W.A. Wargin, M.S. Boosalis, W.J. Wallis, S. Case, J.R. Keefer, and et al. Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers J. Clin. Pharmacol. 51 8 2011 1186 1194
15. H. Tirandaz, and E. Mohammadi Efficient tumor targeting by anaerobic butyrate-producing bacteria Med. Hypotheses 80 5 2013 675 678
16. S. Elangovan, R. Pathania, S. Ramachandran, S. Ananth, R.N. Padia, L. Lan, and et al. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival Cancer Res. 74 4 2014 1166 1178
17. E.G. Sander, R.G. Warner, H.N. Harrison, and J.K. Loosli The stimulatory effect of sodium butyrate and sodium propionate on the development of rumen mucosa in the young calf J. Dairy Sci. 42 9 1959 1600 1605
18. F.Y. Wang, J.M. Liu, H.H. Luo, A.H. Liu, and Y. Jiang Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice World J. Gastroenterol. 21 27 2015 8340 8351
19. T. Watanabe, K. Higuchi, K. Tominaga, Y. Fujiwara, and T. Arakawa Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta Gut 48 6 2001 774 781
20. K. Ganguly, and S. Swarnakar Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin J. Pineal Res. 47 1 2009 43 55
21. P.C. Konturek, T. Brzozowski, G. Burnat, A. Szlachcic, J. Koziel, S. Kwiecien, and et al. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats J. Physiol. Pharmacol. 61 4 2010 429 436
22. M. Tuorkey, and K. Karolin Anti-ulcer activity of curcumin on experimental gastric ulcer in rats and its effect on oxidative stress/antioxidant, IL-6 and enzyme activities Biomed. Environ. Sci. 22 6 2009 488 495
23. S. Swarnakar, A. Mishra, K. Ganguly, and A.V. Sharma Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice J. Pineal Res. 43 1 2007 56 64
24. B.R. Al, F. Al-Bayaty, A.M.M. Jamil, A.M. Abdualkader, H.A. Hadi, H.M. Ali, and et al. In vivo antioxidant and antiulcer activity of Parkia speciosa ethanolic leaf extract against ethanol-induced gastric ulcer in rats PLoS One 8 5 2013 e64751
25. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 2 1979 351 358
26. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, and et al. Determination of carbonyl content in oxidatively modified proteins Methods Enzymol. 186 1990 464 478
27. D.W. Piper, D. Whitecross, P. Leonard, and A. Clarke Alcian blue binding properties of gastric juice Gastroenterology 59 4 1970 534 538
28. W.J. den Hollander, and E.J. Kuipers Current pharmacotherapy options for gastritis Expert. Opin. Pharmacother. 13 18 2012 2625 2636
29. A. Franke, S. Teyssen, and M.V. Singer Alcohol-related diseases of the esophagus and stomach Dig. Dis. (Basel, Switzerland) 23 3-4 2005 204 213
30. H. Al-Jiboury, and J.D. Kaunitz Gastroduodenal mucosal defense Curr. Opin. Gastroenterol. 28 6 2012 594 601
31. H.S. Falcao, I.R. Mariath, M.F. Diniz, L.M. Batista, and J.M. Barbosa-Filho Plants of the American continent with antiulcer activity Phytomedicine 15 1-2 2008 132 146
32. A. Robert Cytoprotection and prostaglandins Klin. Wochenschr. 64 Suppl. 7 1986 40 43
33. S. Szabo, J.S. Trier, and P.W. Frankel Sulfhydryl compounds may mediate gastric cytoprotection Science 214 4517 1981 200 202
34. F. Megraud The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy Ther. Adv. Gastroenterol. 5 2 2012 103 109
35. K. Imase, M. Takahashi, A. Tanaka, K. Tokunaga, H. Sugano, M. Tanaka, and et al. Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota Microbiol. Immunol. 52 3 2008 156 161
36. A. Armuzzi, F. Cremonini, F. Bartolozzi, F. Canducci, M. Candelli, V. Ojetti, and et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy Aliment. Pharmacol. Ther. 15 2 2001 163 169
37. A.A. Salyers, A. Gupta, and Y. Wang Human intestinal bacteria as reservoirs for antibiotic resistance genes Trends Microbiol. 12 9 2004 412 416
38. A.E. van den Bogaard, and E.E. Stobberingh Epidemiology of resistance to antibiotics. Links between animals and humans Int. J. Antimicrob. Agents 14 4 2000 327 335
39. Gut microbiota: Butyrate might regulate intestinal immune tolerance to commensal microbiota Nat. Rev. Gastroenterol. Hepatol. 11 2 2014 74
40. H. Yonezawa, T. Osaki, T. Hanawa, S. Kurata, C. Zaman, T.D. Woo, and et al. Destructive effects of butyrate on the cell envelope of Helicobacter pylori J. Med. Microbiol. 61 Pt 4 2012 582 589
41. S.A. Kripke, A.D. Fox, J.M. Berman, R.G. Settle, and J.L. Rombeau Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids JPEN J. Parenter. Enteral Nutr. 13 2 1989 109 116
42. A. Wachtershauser, and J. Stein Rationale for the luminal provision of butyrate in intestinal diseases Eur. J. Nutr. 39 4 2000 164 171
43. B. Polat, Y. Albayrak, B. Suleyman, H. Dursun, F. Odabasoglu, M. Yigiter, and et al. Antiulcerative effect of dexmedetomidine on indomethacin-induced gastric ulcer in rats Pharmacol. Rep. 63 2 2011 518 526
44. F.J. Andrews, C. Malcontenti, and P.E. O'Brien Sequence of gastric mucosal injury following ischemia and reperfusion. Role of reactive oxygen metabolites Dig. Dis. Sci. 37 9 1992 1356 1361
45. W.F. Li, D.J. Hao, T. Fan, H.M. Huang, H. Yao, and X.F. Niu Protective effect of chelerythrine against ethanol-induced gastric ulcer in mice Chem. Biol. Interact. 208 2014 18 27
46. W. Li, H. Huang, X. Niu, T. Fan, Q. Mu, and H. Li Protective effect of tetrahydrocoptisine against ethanol-induced gastric ulcer in mice Toxicol. Appl. Pharmacol. 272 1 2013 21 29
47. M. Asim, R. Chaturvedi, S. Hoge, N.D. Lewis, K. Singh, D.P. Barry, and et al. Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos c-Jun activator protein-1 complex that causes apoptosis in macrophages J. Biol. Chem. 285 26 2010 20343 20357
48. H.L. Wu, X. Gao, Z.D. Jiang, Z.T. Duan, S.K. Wang, B.S. He, and et al. Attenuated expression of the tight junction proteins is involved in clopidogrel-induced gastric injury through p38 MAPK activation Toxicology 304 2013 41 48
49. X.J. Luo, B. Liu, Z. Dai, T.B. Li, N.S. Li, X.J. Zhang, and et al. Expression of apoptosis-associated microRNAs in ethanol-induced acute gastric mucosal injury via JNK pathway Alcohol 47 6 2013 481 493
50. A. Gozzini, E. Rovida, S.P. Dello, S. Galimberti, and V. Santini Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts Cancer Res. 63 24 2003 8955 8961
51. X.Z. Huang, Z.R. Li, L.B. Zhu, H.Y. Huang, L.L. Hou, and J. Lin Inhibition of p38 mitogen-activated protein kinase attenuates butyrate-induced intestinal barrier impairment in a caco-2 cell monolayer model J. Pediatr. Gastroenterol. Nutr. 59 2 2014 264 269
52. S. Khan, and G.B. Jena Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat Chem. Biol. Interact. 213C 2014 1 12
53. V. Singh, H.S. Bhatia, A. Kumar, A.C. de Oliveira, and B.L. Fiebich Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia Neuroscience 2014
54. N. Singh, A. Gurav, S. Sivaprakasam, E. Brady, R. Padia, H. Shi, and et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis Immunity 40 1 2014 128 139
55. A. Brioschi, G.P. Zara, S. Calderoni, M.R. Gasco, and A. Mauro Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug Molecules 13 2 2008 230 254
56. R. Heidor, J.F. Ortega, A. de Conti, T.P. Ong, and F.S. Moreno Anticarcinogenic actions of tributyrin, a butyric acid prodrug Curr. Drug Targets 13 14 2012 1720 1729
57. A. Patnaik, E.K. Rowinsky, M.A. Villalona, L.A. Hammond, C.D. Britten, L.L. Siu, and et al. A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies Clin. Cancer Res. 8 7 2002 2142 2148